March 17 (Reuters) - Transgene Biotek Ltd TRBL.BO :* TRANSGENE BIOTEK LTD SAYS ENTERED INTO AN AGREEMENT WITH NEODEL PHARMA PVT LTD.* TRANSGENE BIOTEK LTD SAYS COLLABORATION FOR PROVIDING...
Sales reported at Rs 0.16 crore
June 3 (Reuters) - Transgene Biotek Ltd TRBL.BO :* TRANSGENE BIOTEK LTD SAYS BOARD HAS APPROVED LICENSING OF TRABIORAL TO GVK BIO
April 27 (Reuters) - Transgene Biotek Ltd TRBL.BO :* INITIATED A PROGRAM OF DRUG DEVELOPMENT AGAINST SARS COVID 19 INFECTIONS
April 10 (Reuters) - Transgene Biotek Ltd TRBL.BO :* TRANSGENE BIOTEK LTD -GOT CERTIFICATE OF PATENT GRANTED BY AUSTRALIA, ON ORAL DELIVERY PLATFORM TECHNOLOGY
March 4 (Reuters) - Transgene Biotek Ltd TRBL.BO :* ACCEPTED RESIGNATION OF VIKRAM POLAVARAPU AS MD* K KOTESWARA RAO IS REAPPOINTED AS MD OF CO WITH IMMEDIATE EFFECT* PASSED RESOLUTION TO...
Jan 8 (Reuters) - Transgene Biotek Ltd TRBL.BO :* SAYS CO GRANTED USA PATENT ON ORAL INSULIN TECHNOLOGY
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
